PRINTED: 05/14/2026
FORM APPROVED
DEPARTMENT OF HEALTH AND HUMAN SERVICES
CENTERS FOR MEDICARE & MEDICAID SERVICES
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
OMB NO. 0938-0391
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X1) MULTIPLE CONSTRUCTION
A. BUILDING: ___________
B. WING: _______________
056185
(X3) DATE SURVEY
COMPLETED
04/17/2018
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
MENIFEE LAKES POST ACUTE
27600 Encanto Dr
Menifee, CA 92586
(X4) ID
PREFIX
TAG
SUMMARY STATEMENT OF DEFICIENCIES
(EACH DEFICIENCY MUST BE PRECEDED BY FULL
REGULATORY OR LSC IDENTIFYING INFORMATION)
ID
PREFIX
TAG
F000
INITIAL COMMENTS
F000
PROVIDER'S PLAN OF CORRECTION
(EACH CORRECTIVE ACTION SHOULD BE
CROSS-REFERENCED TO THE APPROPRIATE
DEFICIENCY)
(X5)
COMPLETE
DATE
The following reflects the findings of the
California Department of Public Health during
an abbreviated standard survey for the
investigation of two complaints.
Complaint numbers CA00580002 and
CA00579963
Representing the California Department of
Public Health: Surveyor Federal/State ID#
34435/2829, HFEN
The inspection was limited to the specific
complaints investigated and does not represent
the findings of a full inspection of the facility.
A deficiency was issued for complaint numbers
CA00580002 and CA00579963.
F757
SS=G
Drug Regimen is Free from Unnecessary
Drugs
CFR(s): 483.45(d)(1)-(6)
F757
04/17/2018
§483.45(d) Unnecessary Drugs-General.
Each resident's drug regimen must be free
from unnecessary drugs. An unnecessary drug
is any drug when used§483.45(d)(1) In excessive dose (including
duplicate drug therapy); or
§483.45(d)(2) For excessive duration; or
§483.45(d)(3) Without adequate monitoring; or
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that
other safeguards provide sufficient protection to the patients . (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days
following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14
days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued
program participation.
FORM CMS-2567(02-99) Previous Versions Obsolete
Event ID: DPWB11
Facility ID: CA240000098
If continuation sheet 1 of 6
PRINTED: 05/14/2026
FORM APPROVED
DEPARTMENT OF HEALTH AND HUMAN SERVICES
CENTERS FOR MEDICARE & MEDICAID SERVICES
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
OMB NO. 0938-0391
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X1) MULTIPLE CONSTRUCTION
A. BUILDING: ___________
B. WING: _______________
056185
(X3) DATE SURVEY
COMPLETED
04/17/2018
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
MENIFEE LAKES POST ACUTE
27600 Encanto Dr
Menifee, CA 92586
(X4) ID
PREFIX
TAG
SUMMARY STATEMENT OF DEFICIENCIES
(EACH DEFICIENCY MUST BE PRECEDED BY FULL
REGULATORY OR LSC IDENTIFYING INFORMATION)
ID
PREFIX
TAG
PROVIDER'S PLAN OF CORRECTION
(EACH CORRECTIVE ACTION SHOULD BE
CROSS-REFERENCED TO THE APPROPRIATE
DEFICIENCY)
(X5)
COMPLETE
DATE
§483.45(d)(4) Without adequate indications for
its use; or
§483.45(d)(5) In the presence of adverse
consequences which indicate the dose should
be reduced or discontinued; or
§483.45(d)(6) Any combinations of the reasons
stated in paragraphs (d)(1) through (5) of this
section.
This REQUIREMENT is not met as evidenced
by:
Based on interview, and record review, the
facility failed to ensure one (Resident A) in a
sample of three residents in a universe of 71
residents, was free from unnecessary
Coumadin (warfarin an anticoagulant or blood
thinner) doses, when the ordered laboratory
test for monitoring therapeutic range (PTProthrombin Time/INR-International
Normalized Ratio) was not carried out.
This failure resulted in excessive warfarin level,
extensive bleeding, and hemorrhagic shock
(severe fluid loss which makes it impossible for
the heart to pump sufficient amount of blood
into the body) for Resident A.
Findings:
On April 5, 2018, at 10 a.m., an unannounced
complaint investigation was conducted at the
facility.
Resident A's record was reviewed. Resident
A,who was 87 years old, was discharged from
the acute hospital and arrived at the facility on
March 17, 2018 with diagnoses that included
congestive heart failure (CHF), atrial fibrillation
(abnormal heart rhythm), and chronic ischemic
heart disease (or CAD [coronary artery
disease] - narrowed arteries causing less blood
FORM CMS-2567(02-99) Previous Versions Obsolete
Event ID: DPWB11
Facility ID: CA240000098
If continuation sheet 2 of 6
PRINTED: 05/14/2026
FORM APPROVED
DEPARTMENT OF HEALTH AND HUMAN SERVICES
CENTERS FOR MEDICARE & MEDICAID SERVICES
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
OMB NO. 0938-0391
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X1) MULTIPLE CONSTRUCTION
A. BUILDING: ___________
B. WING: _______________
056185
(X3) DATE SURVEY
COMPLETED
04/17/2018
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
MENIFEE LAKES POST ACUTE
27600 Encanto Dr
Menifee, CA 92586
(X4) ID
PREFIX
TAG
SUMMARY STATEMENT OF DEFICIENCIES
(EACH DEFICIENCY MUST BE PRECEDED BY FULL
REGULATORY OR LSC IDENTIFYING INFORMATION)
ID
PREFIX
TAG
PROVIDER'S PLAN OF CORRECTION
(EACH CORRECTIVE ACTION SHOULD BE
CROSS-REFERENCED TO THE APPROPRIATE
DEFICIENCY)
(X5)
COMPLETE
DATE
and oxygen to the heart).
Resident A's facility records included copies of
records from the acute hospital which
indicated:
-Acute hospital history and physical, dated
March 16, 2018, " ...87 year old female
...Coumadin (significant side effects include
gastrointestinal bleeding and stroke resulting in
serious injury or death) already with
supratherapeutic (level greater than would be
used for treatment) INR..." The document
further indicated Resident A's INR on on March
15, 2018 was critical at 5.5 (normal range is
between 0.9 and 1.1).
-Acute hospital "SUMMARY OF CARE", which
included discharge instructions to no longer
take Coumadin 1 mg daily, "COAGULATION
3/17/2018 05:43:00 INR: 5.8 ...PT: 61.7-Normal
range between 9.3 and 11.2 ..."
Resident A's facility record further indicated:
-Facility history and physical dated March 19,
2018 indicated, " ...Pt (patient) was placed on
Keflex (antibiotic) for uti (urinary tract infection)
and had her Coumadin (used to treat a blood
clot in the lungs) held due to elevated INR ..."
The document further indicated Resident A's
current medication included Coumadin, "
...Take as directed by Anticoagulation clinic
(sic) to thin blood ..."
-Physician's order dated, March 19, 2018,
"Hold Coumadin today, PT/INR (used to
monitor how the blood thinning medication is
working) 3/20/2018"
-Physician's order dated, March 21, 2018,
"Coumadin 2 mg (milligrams) po (by mouth)
daily, next INR 3/23/18"
FORM CMS-2567(02-99) Previous Versions Obsolete
Event ID: DPWB11
Facility ID: CA240000098
If continuation sheet 3 of 6
PRINTED: 05/14/2026
FORM APPROVED
DEPARTMENT OF HEALTH AND HUMAN SERVICES
CENTERS FOR MEDICARE & MEDICAID SERVICES
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
OMB NO. 0938-0391
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X1) MULTIPLE CONSTRUCTION
A. BUILDING: ___________
B. WING: _______________
056185
(X3) DATE SURVEY
COMPLETED
04/17/2018
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
MENIFEE LAKES POST ACUTE
27600 Encanto Dr
Menifee, CA 92586
(X4) ID
PREFIX
TAG
SUMMARY STATEMENT OF DEFICIENCIES
(EACH DEFICIENCY MUST BE PRECEDED BY FULL
REGULATORY OR LSC IDENTIFYING INFORMATION)
ID
PREFIX
TAG
PROVIDER'S PLAN OF CORRECTION
(EACH CORRECTIVE ACTION SHOULD BE
CROSS-REFERENCED TO THE APPROPRIATE
DEFICIENCY)
(X5)
COMPLETE
DATE
-Physician's order dated, March 23, 2018,
"Cont. (continue) Coumadin 2 mg po daily, next
INR 3/26/2018"
-Physician's order dated, March 26, 2018,
"Sent to (acute hospital) ER (emergency room)
911 ...vaginal bleeding"
-The medication administration record indicated
Resident A received Coumadin 2 mgs from
March 22 through 25, 2018.
On April 5, 2018, at 11:45 a.m., Resident A's
record was reviewed with the Director of
Nursing (DON). The DON stated Resident A
was transferred to the acute hospital on March
26, 2018 because around 1:45 p.m., Resident
A was noted to have copious amount of red
blood from the vaginal area.
The DON stated Resident A belonged to a
specific managed care group who had their
own anticoagulation clinic that managed all of
the Coumadin dosing and monitoring for all
residents that were under the managed care
group.
The DON stated the managed care
anticoagulation clinic gave the order to start
Resident A's Coumadin 2 mgs daily on March
20, 2018. The DON stated the physician's
order dated March 21, 2018, "Coumadin 2 mg
(milligrams) po (by mouth) daily, next INR
3/23/18" was based from the "(name of
managed care group) Anticoagulation Service
Supplemental Order" dated, March 20, 2018.
The supplemental order indicated: Last INR
Result: INR 2.4 3/20/2018, Warfarin Dosing
Instructions: start 2mg daily, Next INR Date:
Follow up date: 03/23/2018.
The DON stated on March 23, 2018, the
FORM CMS-2567(02-99) Previous Versions Obsolete
Event ID: DPWB11
Facility ID: CA240000098
If continuation sheet 4 of 6
PRINTED: 05/14/2026
FORM APPROVED
DEPARTMENT OF HEALTH AND HUMAN SERVICES
CENTERS FOR MEDICARE & MEDICAID SERVICES
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
OMB NO. 0938-0391
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X1) MULTIPLE CONSTRUCTION
A. BUILDING: ___________
B. WING: _______________
056185
(X3) DATE SURVEY
COMPLETED
04/17/2018
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
MENIFEE LAKES POST ACUTE
27600 Encanto Dr
Menifee, CA 92586
(X4) ID
PREFIX
TAG
SUMMARY STATEMENT OF DEFICIENCIES
(EACH DEFICIENCY MUST BE PRECEDED BY FULL
REGULATORY OR LSC IDENTIFYING INFORMATION)
ID
PREFIX
TAG
PROVIDER'S PLAN OF CORRECTION
(EACH CORRECTIVE ACTION SHOULD BE
CROSS-REFERENCED TO THE APPROPRIATE
DEFICIENCY)
(X5)
COMPLETE
DATE
managed care anticoagulation clinic gave the
order to continue Coumadin 2 mgs daily for
Resident A. The "(name of managed care
group) Anticoagulation Service Supplemental
Order" dated, March 23, 2018, indicated: Last
INR Result: INR 2.4 3/20/2018, Warfarin
Dosing Instructions: continue 2mg daily, Next
INR Date: Follow up date: 03/26/2018.
The Coumadin dose was continued based on
PT/INR result from March 20, 2018.
Review of Resident A's printed laboratory
results and the "LAB ORDER LOG FOR (name
of managed care group) PATIENTS ONLY"
with the DON indicated, the PT/INR ordered for
Resident A to be drawn on March 23, 2018 was
not carried out.
The DON confirmed there was no documented
evidence that the facility was aware and
followed up on the missed PT/INR ordered for
March 23, 2018.
On April 5, 2018, at 1 p.m., the facility Case
Manager (CM) was interviewed with the DON.
The CM stated part of her responsibility was
coordinating the care of residents that
belonged to the managed care group. The CM
stated she called the managed care
anticoagulation clinic today. The CM stated
she was told the PT/INR for Resident A was
not carried out on March 23, 2018, because
they (managed care group anticoagulation
clinic laboratory) went to the wrong address for
Resident A.
Both the DON and the CM agreed the facility
should have been monitoring Resident A's
Coumadin dosing and PT/INR results.
Resident A was subsequently admitted to the
acute hospital on March 26, 2018. The acute
FORM CMS-2567(02-99) Previous Versions Obsolete
Event ID: DPWB11
Facility ID: CA240000098
If continuation sheet 5 of 6
PRINTED: 05/14/2026
FORM APPROVED
DEPARTMENT OF HEALTH AND HUMAN SERVICES
CENTERS FOR MEDICARE & MEDICAID SERVICES
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
OMB NO. 0938-0391
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X1) MULTIPLE CONSTRUCTION
A. BUILDING: ___________
B. WING: _______________
056185
(X3) DATE SURVEY
COMPLETED
04/17/2018
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
MENIFEE LAKES POST ACUTE
27600 Encanto Dr
Menifee, CA 92586
(X4) ID
PREFIX
TAG
SUMMARY STATEMENT OF DEFICIENCIES
(EACH DEFICIENCY MUST BE PRECEDED BY FULL
REGULATORY OR LSC IDENTIFYING INFORMATION)
ID
PREFIX
TAG
PROVIDER'S PLAN OF CORRECTION
(EACH CORRECTIVE ACTION SHOULD BE
CROSS-REFERENCED TO THE APPROPRIATE
DEFICIENCY)
(X5)
COMPLETE
DATE
hospital emergency department records
indicated Resident A's INR was 8.2 on March
26, 2018.
The acute hospital emergency department
physician note, dated, March 26, 2018, 3:27
p.m, indicated, "...given the severity of bleeding
2 units of fresh frozen plasma (the liquid portion
of human blood that has been frozen and
preserved, used for blood transfusion) was
ordered given her INR of over 8 in the context
of heavy vaginal/GI (gastrointestinal)
bleeding...Patient dropped her pressure (blood
pressure) to become 80 over palp
(palpation)...this time the patient remains
hypotensive (low blood pressure)...Condition:
Serious..."
The acute hospital history and physical, dated
March 26, 2018, indicated " ...Bleeding
seemingly was so extensive that it was not
possible to say if this was vaginal or rectal
bleed ...Markedly increased INR (due to
excessive warfarin) ...Hypotension, due to
recurrent bleeding ..."
The acute hospital physician progress note,
dated March 27, 2018, 4:53 p.m., indicated "on
Levophed (used to treat life-threatening low
blood pressure)...received 3 units of blood and
4 units of fresh frozen plasma..."
The acute hospital note dated, March 28, 2018,
3:23 p.m., indicated Resident A's "Admission
Diagnosis(es): 1.) Extensive vaginal/rectal
bleed, 2.) Excessive warfarin level... Primary
Diagnosis: Hemorrhagic shock ..."
FORM CMS-2567(02-99) Previous Versions Obsolete
Event ID: DPWB11
Facility ID: CA240000098
If continuation sheet 6 of 6